Stockscreener 앱 받기
31.80
2.38%
0.74
시간 외 거래:
31.80
전일 마감가:
$31.06
열려 있는:
$31
하루 거래량:
263.46K
Relative Volume:
1.41
시가총액:
$453.85M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.51%
1개월 성능:
+42.35%
6개월 성능:
+87.39%
1년 성능:
-51.82%
1일 변동 폭
$30.65
$33.06
1주일 범위
$27.22
$35.47
52주 변동 폭
$6.875
$74.49
Neurogene Inc Stock (NGNE) Company Profile
명칭
Neurogene Inc
전화
(877) 237-5020
주소
535 W 24TH STREET, NEW YORK
NGNE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
31.80 | 443.29M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Craig Hallum | Buy |
| 2025-05-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-06-11 | 개시 | Robert W. Baird | Outperform |
| 2024-04-29 | 개시 | Leerink Partners | Outperform |
| 2024-03-21 | 개시 | William Blair | Outperform |
| 2024-01-08 | 개시 | H.C. Wainwright | Buy |
| 2024-01-05 | 개시 | Stifel | Buy |
| 2024-01-04 | 개시 | TD Cowen | Outperform |
모두보기
Neurogene Inc 주식(NGNE)의 최신 뉴스
Volume spikes in Neurogene Inc. stock – what they mean2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
Statistical indicators supporting Neurogene Inc.’s strengthTreasury Yields & Technical Analysis for Trade Confirmation - newser.com
How to use a screener to detect Neurogene Inc. breakoutsMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com
Using AI based signals to follow Neurogene Inc.2025 AllTime Highs & Detailed Earnings Play Strategies - newser.com
Can a trend reversal in Neurogene Inc. lead to recoveryJuly 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Will Neurogene Inc. (UU8) stock profit from automation wave2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
Why Neurogene Inc. stock is popular among millennialsWeekly Volume Report & Daily Price Action Insights - newser.com
Risk adjusted return profile for Neurogene Inc. analyzed2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Is Neurogene Inc. (UU8) stock supported by strong fundamentalsProduct Launch & Verified Momentum Stock Alerts - newser.com
Is Neurogene Inc. stock a buy on dipsWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com
Why Neurogene Inc. (UU8) stock could be top winnerQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com
Tools to monitor Neurogene Inc. recovery probabilityTrade Exit Summary & Consistent Growth Stock Picks - newser.com
Applying big data sentiment scoring on Neurogene Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Is Neurogene Inc. (UU8) stock among top earnings playsDip Buying & Safe Swing Trade Setups - newser.com
Can Neurogene Inc. (UU8) stock sustain institutional flowsQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
Why Neurogene Inc. stock could outperform in 2025July 2025 Recap & High Conviction Buy Zone Picks - newser.com
Will Neurogene Inc. stock outperform growth indexesEarnings Growth Summary & Verified Momentum Watchlists - newser.com
Why Neurogene Inc. stock remains a top recommendationWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Signal strength of Neurogene Inc. stock in tech scanners2025 Volume Leaders & Free Verified High Yield Trade Plans - newser.com
Does Neurogene Inc. qualify in momentum factor screeningBond Market & AI Based Buy/Sell Signal Reports - newser.com
Why Neurogene Inc. stock remains undervaluedPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Will Neurogene Inc. (UU8) stock keep high P E multiplesPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Is Neurogene Inc. (UU8) stock a buy before new product rollout - newser.com
Price action breakdown for Neurogene Inc.July 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
Why Neurogene Inc. (UU8) stock could break out in 20252025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Combining price and volume data for Neurogene Inc.July 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Neurogene Inc. $NGNE Shares Bought by Jennison Associates LLC - MarketBeat
Neurogene Inc (NGNE) 재무 분석
Neurogene Inc (NGNE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):